Plain-English translation of NCT03699228 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This is a large nationwide study in China that uses CT scan technology โ the same scans already done for lung cancer screening โ to measure three important health markers: bone density (to detect weak bones), belly fat, and liver fat. Researchers are combining information from 30,000 people to understand how common bone weakness, obesity, and fatty liver disease are in the general population.
Many people have weak bones, excess belly fat, or fatty liver disease without knowing it. This study wants to see how useful CT scans already being done for other reasons could be to catch these conditions early, and to understand how widespread these health problems are in China.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you qualify, you would undergo a low-dose chest CT scan as part of your regular health check-up. The researchers will then use special computer software to analyze the scan images you already had, measuring your bone density, belly fat, and liver fat. This is a one-time analysis of existing scan data โ no additional procedures or visits are needed beyond your routine check-up.
AI-generated summary from trial data ยท Jun 6, 2026 ยท Not medical advice
China
Sponsor
Beijing Jishuitan Hospital
Collaborators
Chinese PLA General Hospital, Ruijin Hospital
Enrollment target
~30,000 participants
Started
December 2017
Primary completion
June 2026
This trial's estimated completion date has passed โ the record may not be fully up to date.
Age range
30 Years โ 90 Years
Last updated on clinicaltrials.gov in August 2025.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
xiaoguang cheng, md
Beijing Jishuitan Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.